Z. Diamant (Leiden, The Netherlands), R. Lever (London, United Kingdom)
Does muscle relaxants agents induced benefits compared to a remifentanil based regimen in hypoxic patient under invasive ventilation?
M. Francois, A. Aurelie (Luxemburg City, Luxembourg)
|  |
Microbiological pattern and risk factors of bacterial colonisation in patients with clinically stable brochiectasis
K. Abdalla, M. Maher, M. Walid (Aleppo, Syrian Arab Republic)
|  |
Pharmacoepidemiologic analysis of medication use for bronchial obstruction therapy
Y. Mostovoy, H. Demchuk (Vinnytsya, Ukraine)
| |
Inhaler technique in stable COPD and those with recurrent admisisons
B. Thompson, W. Rees, N. Fransham, C. Smith, V. Konala, K. Lewis (Wales, United Kingdom)
| |
Inhaled anticholinergic drugs and risk of acute urinary retention
A. Afonso, K. Verhamme, B. Stricker, M. Sturkenboom, G. Brusselle (Rotterdam, Netherlands; Ghent, Belgium)
| |
Comparison of the effects of beclomethasone HFA (BDP- HFA) pMDI with beclomethasone CFC (BDP-CFC) pMDI on 10-hour urinary cortisol in healthy subjects
N. Syed, C. J. Po, S. Chachad, M. Gole, S. Purandare, A. Sule, A. Lulla (Mumbai, India)
| |
Inhaled glucocorticoids and β-2 agonists regulate cytokine secretion from circulating blood cells
M. Gencay, J. Ruediger, M. Tamm, M. Roth (Basel, Switzerland)
| |
Poor knowledge of health care professionals in proper handling of inhaler devices
B. Khassawneh, K. Alzoubi, N. AL-Omari (Irbid, Jordan)
| |
Effectiveness of N-acetyl cyctein (NAC) to reduce cough when used together with other over-the-counter (OTC) in common cold (a preliminary study)
N. Mansoori, S. Fallah Tafti, B. Mokri, A. Cheraghvandi, F. Talischi (Tehran, Islamic Republic Of Iran)
| |
The effect of oral corticosteroids on spirometric parameters in chronic obstructive pulmonary disease
N. Rezaie, Z. Sharifie Rad (Tehran, Islamic Republic Of Iran)
| |
Asthma symptoms in patient treated with fluticasone and fluticasone/Salmeterol combination
B. Janackov, Z. Stojanovski, B. Sabani (Skopje, Fyrom)
| |
Could montelukast reduce asthma exacerbations?
Z. Paunovic (Nis, Serbia And Montenegro)
| |
Dosage form proportionality, dose proportionality and pharmacokinetics (PK) of mometasone furoate (MF) and formoterol fumarate (F) from three combination MDI formulations
B. Patterson, S. Perry, L. Zhang Auberson, R. Morgan, S. Maton, P. Dewland, S. Pascoe, J. Hubbell (Horsham, Merthyr Tydfil, United Kingdom; Basel, Switzerland; NJ, United States Of America)
| |
Comparison of immunomodulating effects among clarithromycin, dexamethasone and levofloxacin on the murine model of mycoplasma pneumoniae pneumonia
S. Hirao, T. Saraya, D. Kurai, H. Wada, H. Ishii, S. Kurata, H. Taguchi, S. Kamiya, T. Akashi, K. Nakagaki, K. Nakata, H. Goto (Tokyo, Saitama, Niigata, Japan)
| |
Validation of a technique used to accurately record and simulate breathing from patients using spacer devices
A. Schultz, P. Sly, T. Le Souëf, P. Le Souëf, S. Devadason (Perth, WA, Australia)
| |